BarnhillRL, FleischliM.Histologic features of congenital melanocytic nevi in infants 1 year of age or younger. J Am Acad Dermatol1995;33:780–785.
18.
AvrilMF, BoitierF, DelaunayM, Influence of pregnancy and hormonal treatments after a melanoma on the course of the disease. A French multicentric study [abstract]. Melanoma Res1997;7:65.
19.
DillmanRO, VandermolenLA, BarthNM, BrandsfordKJ. Malignant melanoma and pregnancy: ten questions. West J Med1996;164:156–161.
20.
DildyGA, MoiseKJ, CarpenterRJ, KlimaT.Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv1989;44:535–540.
21.
Ruiz-MaldonadoR, Orozco-CovarrubiasL.Malignant melanoma in children. A review. Arch Dermatol1997;133:363–371.
22.
CeballosPI, Ruiz-MaldonadoR, MimhMCJr.Melanoma in children. N Engl J Med1995;332:656–662.
23.
GottronH, DertlerW.Zur Frage des Übertritts von Malanogen von der Mutter auf den Säugling über die Muttermilch. Arch Dermatol Syph1940;181:91.
24.
WeberFP, SchwarzE, HellenschmiedR.Spontaneous inoculation of melanotic sarcoma from mother to foetus: report of a case. BMJ1930;1:537–539.
25.
DargeonHW, EversoleJW, DelducaV.Malignant melanoma in an infant. Cancer1950;3:299.
26.
AronssonS.A case of transplacental tumor metastasis. Acta Pediatr Scand1963;52:123–134.
27.
BrodskyI, BarenM, KahnSB, LewisG, TellemM.Metastatic malignant melanoma from mother to fetus. Cancer1965;18:1048–1054.
28.
AngelucciD, NataliPG, AmerioPL, Rapid perinatal growth mimicking malignant transformation in a giant congenital melanocytic nevus. Hum Pathol1991;22:297–301.
BorgesAF, LinebergerAS. Malignant melanoma without metastasis in a giant nevus. Ann Plast Surg1984;12:454–460.
31.
CarrollCB, CeballosP, PerryAE, MimhMCJr., SpencerSK. Severely atypical medium-sized congenital nevus with widespread satellitosis and placental deposits in a neonate: the problem of congenital melanoma and its simulants. J Am Acad Dermatol1994;30:825–828.
32.
FishJ, SmithEB, CanbyJP. Malignant melanoma in childhood. Pediatr Surg1966;59:309–315.
33.
KoyamaT, MurakamiM, NishiharaO, MasudaT.Congenital melanoma: a case suggesting rhabdomyogenic differentiation. Pediatr Dermatol1996;13:389–393.
34.
PackGT, DavisJ.Nevus giganticus pigmentosus with malignant transformation. Surgery1961;49:347–354.
35.
RothM, Grant-KelsJM, KuhnMK, GreenbergRD, HurwitzS.Melanoma in children. J Am Acad Dermatol1990;22:265–274.
36.
SchneidermanH, WuAY-Y, CampbellWA, Congenital melanoma with multiple prenatal metastases. Cancer1987;60:1371–1377.
37.
SweetLK, ConnertyHV. Congenital melanoma: report of a case in which antenatal metastasis occured. Am J Dis Child1941;62:1029–1040.
38.
WorkmanML, KayeVN, AndersonPM, CunninghamBL. Malignant melanoma with evidence of maturation arising from a giant congenital nevocellular nevus. Ann Plast Surg1992;28:381–385.
39.
HendricksonMR, RossJC. Neoplasms arising in congenital giant nevi: morphologic study of seven cases and a review of the literature. Am J Surg Pathol1981;5:109–135.
40.
ManciantiML, ClarkWH, HayesFA, HerlynM.Malignant melanoma simulants arising in congenital melanocytic nevi do not show evidence for a malignant phenotype. Am J Pathol1990;136:817–829.
41.
ClarkWHJr., ElderDE, GuerryDIV. Dysplastic nevi and malignant melanoma. In: FarmerE, HoodE, eds. Pathology of the Skin. Norwalk: Appleton and Lange, 1990;684–756.
DeDavidM, OrlowSJ, ProvostN, Neurocutaneous melanosis: clinical features of large ongenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol1996;35:529–538.
44.
KadonagaJN, FriendIJ. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol1991;24:747–755.
45.
SasakiY, KobayashiS, ShimizuH, NishikawaT.Multiple nodular lesions seen in a patient with neurocutaneous melanosis. J Dermatol1996;23:828–831.
46.
GreenLJ, NandaVS, RothGM, BarrRJ. Neurocutaneous melanosis and Dandy-Walker syndrome in an infant. Int J Dermatol1997;36:356–359.
47.
ChaloupkaJC, WolfRJ, VarmaPK. Neurocutaneous melanosis with the Dandy-Walker malformation: a possible rare pathoetiologic association. Neuroradiology1996; 38:486–489.
48.
CraverRD, GolladaySE, WarrierRP, GatesAJ, NelsonJS. Neurocutaneous melanosis with Dandy-Walker malformation complicated by primary spinal leptomeningeal melanoma. J Child Neurol1996;11:410–414.
49.
KadonagaJN, BarkovichAJ, EdwardsMS, FriedenIJ. Neuro-cutaneous melanosis in association with the Dandy-Walker complex. Pediatr Dermatol1992;9:37–43.
50.
KopfAW, BartRS, HennesseyP.Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol1979;1:123–130.
51.
SwerdlowAJ, EnglishJSC, QiaoZ.The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol1995;32:595–599.
KroonS, ClemmensenOJ, HastrupN.Incidence of congenital melanocytic nevi in newborn babies in Denmark. J Am Acad Dermatol1987;17:422–426.
59.
RhodesAR, SoberAJ, DayCL, The malignant potential of small congenital nevocellular nevi. J Am Acad Dermatol1982;6:230–241.
60.
SpatzA, RuiterD, HardmeierT, Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects. Int J Cancer1996;68:317–324.
61.
ClarkW, ReimerR, GreenMH. Origin of familial malignant melanoma from heritable melanocytic lesion. Arch Dermatol1978;114:732–738.
62.
AlbertLS, RhodesAR, SoberAJ. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives. J Am Acad Dermatol1990;22:69–75.
63.
CookeKR, SpearsGFS, ElderDE, Dysplastic nevi in a population-based survey. Cancer1989;63:1240–1244.
64.
CrutcherWA, SagebielRW. Prevalence of dysplastic nevi in a community practice [letter]. Lancet1984;1:729.
65.
KellyJW, HollyEA, ShpallSN, The distribution of melanocytic nevi in melanoma patients and control subjects. Australas J Dermatol1989;30:1–8.
66.
NordlundJJ, KirkwoodJ, ForgetBM, Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res1985;45:1855–1861.
67.
SwerlowAJ, EnglishJ, MacKieRM, Benign melanocytic nevi as a risk factor for malignant melanoma. BMJ1986;292:1555–1559.
68.
GreeneMH, ClarkWHJr., TuckerMA, KraemerKH, ElderDE, FraserMC. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med1985;102:458–465.
69.
NovakovicB, ClarkWH, FearsTF, FraserMC, TuckerMA. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families. J Am Acad Dermatol1995;33:631–636.
70.
WhitemanDC, ValeryP, McWhirterW, GreenAC. Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer1997;70:26–31.
71.
GoldenhershMA, SavinRC, BarnhillRL, StennKS. Malignant blue nevus: case report and literature review. J Am Acad Dermatol1988;19:712–722.
72.
LermanRI, MurrayD, O'HaraJM, BooherRJ, FooteFWJr.Malignant melanoma of childhood. A clinicopathologic study and a report of 12 cases. Cancer1970;25:436–49.
73.
PrattCB, PalmerMK, ThatcherN, CrowtherD.Malignant melanoma in children and adolescents. Cancer1981;47:392–397.
74.
BorregoL, HernandezSantana J, BaezO, HernandezHernandez B.Naevus spilus as a precursor of cutaneous melanoma: report of a case and literature review. Clin Exp Dermatol1994;19:515–517.
75.
CawleyEP. Genetic aspects of malignant melanoma. Arch Dermatol1952;65:440–450.
76.
AitkenJF, GreenAC, MacLennanR, YoulP, MartinNG. The Queensland familial melanoma project: study design and characteristics of participants. Melanoma Res1996;6:155–165.
77.
GreeneMH, FraumeniJF. The hereditary variant of familial melanoma. In: ClarkWJ, GoldmanL, MastrangeloM, eds. Human Malignant Melanoma. New York: Grune and Stratton, 1979;139–166.
78.
GrangeF, ChompretA, Guilloud-BatailleM, Comparison between familial and non-familial melanoma in France. Arch Dermatol1995;131:1154–1159.
79.
SerranoM, HannonGJ, BeachD.A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature1993;366:704–707.
80.
SerranoM, Gomez-LahozE, DePinhoRA, BeachD, Bar-SagiD.Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science1995;267:249–252.
81.
LukasJ, ParryD, AagaardL, Retinoblastoma-protein-dependant cell-cycle inhibition by the tumour suppressor p16. Nature1995;375:503–506.
82.
KambA, Shattuck-EidensD, EelesR, Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet1994;1:97–99.
83.
SoufirN, AvrilMF, ChompretA, Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum Mol Genet1998;7:209–216.
84.
ZuoL, WegerJ, YangQ, Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet1996;8:15–21.
85.
TanakaK, WoodRD. Xeroderma pigmentosum and nucleotide excision repair of DNA. Trends Biochem Sci1994;19:83–86.
86.
StaryA, SarasinA.The genetic basis of xeroderma pigmentosum and trichodystrophy syndromes. Cancer Surv1996;26:155–171.
87.
KraemerKH, LeeMM, ScottoJ.Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol1987;123:241–250.
88.
KraemerKH, LeeMM, AndrewsAD, LambertWC. The role of sunlight and DNA repair in melanoma and non-melanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol1994;130:1018–1021.
89.
BairdEA, McHenryPM, MacKieRM. Effect of maintenance chemotherapy in childhood on numbers of melanocytic nevi. BMJ1992;305:799–801.
De WitPEJ, De VaanGAM, De BooTHM, LemmensWAJG, RampenFHJ. Prevalence of naevocytic naevi after chemotherapy for childhood cancer. Med Pediatr Oncol1990;18:336–338.
92.
DuvicM, LoweL, RapiniRP, RodriguezS, LevyML. Eruptive dysplastic nevi associated with human immunodeficiency virus infection. Arch Dermatol1989;125:397–401.
93.
HughesBR, CunliffeWJ, BaileyCC. The development of excess numbers of benign melanocytic naevi in children after chemotherapy for malignancy. BMJ1989;299:88–91.
94.
IppenH, PrindullG.Pimented naevi after mercaptopurine. BMJ1984;289:734.
95.
GreenA, SmithP, McWhirterW, Melanocytic naevi and melanoma in survivors of childhood cancer. Br J Cancer1993;67:1053–1057.
96.
International Agency for Research on Cancer.Solar and Ultraviolet Radiation. Lyon: International Agency for Research on Cancer, 1992.
97.
HarrisonSL, MacLennanR, SpeareR, WronskiI.Sun exposure and melanocytic naevi in young Australian children. Lancet1994;344:1529–1532.
98.
LutherH, AltmeyerP, GarbeC, Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol1996;13:1473–1478.
99.
RiversJK, MacLennanR, KellyJW, The Eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesions. J Am Acad Dermatol1995;32:957–963.
100.
BrodkinRH, AltmanEM. Controlling malignant melanoma. A focus on pediatricians. Am J Dis Child1993;147:875–881.
101.
LartigauE, SpatzA, AvrilM-F, Melanoma arising de novo in childhood: experience of the Gustave-Roussy Institute. Melanoma Res1995;5:117–122.
102.
BarnhillRL, FlotteTJ, FleischliM, Perez-AtaydeA.Cutaneous melanoma and atypical spitz tumors in childhood. Cancer1995;76:1833–1845.
103.
BoddieAWJr., SmithJLJr., McBrideCM. Malignant melanoma in children and young adults: effect of diagnosis criteria on staging and end results. South Med J1978;71:1074–1078.
104.
MehreganAH, MehreganDA. Malignant melanoma in childhood. Cancer1993;71:4096–4103.
105.
PetersMS, GoellnerJR. Spitz naevi and malignant melanomas of childhood and adolescence. Histopathology1986;10:1289–1302.
106.
TatePS, RonanSG, FeuchtKA, EngAM, Das GuptaTK. Melanoma in childhood and adolescence: clinical and pathological features of 48 cases. J Pediatr Surg1993;28:217–222.
107.
ZhuN, WarrR, CaiR, RigbyHS, BurdDAR. Cutaneous malignant melanoma in the young. Br J Plast Surg1997;50:10–14.
108.
CochranAJ, BaillyC, PaulE, RemottiF.Melanocytic Tumors: A Guide to Diagnosis. Philadelphia: Lippincott-Raven, 1997.
109.
ScalzoDA, HidaCA, TothG, SoberAJ, MihmMCJr.Childhood melanoma: a clinicopathological study of 22 cases. Melanoma Res1997;7:63–68.
WeedonD, LittleJH. Spindle and epitheloid cell nevi in children and adults. A review of 211 cases of the Spitz nevus. Cancer1977;40:217–225.
112.
CrottyKA, McCarthySW, PalmerAA, Malignant melanoma in childhood: a clinicopathologic study of 13 cases and comparison with Spitz nevi. World J Surg1992;16:179–185.
113.
Handfield-JonesSE, SmithNP. Malignant melanoma in childhood. Br J Dermatol1996;134:607–616.
114.
ClarkWHJr., ElderDE, Van HornM.The biologic forms of malignant melanoma. Hum Pathol1984;17:443–450.
115.
SpatzA, ZimmermannU, AvrilMF, SarasinA, DuvillardP.Melanoma associated with xeroderma pigmentosum. A histopathological analysis of 23 cases [abstract]. Melanoma Res1997;7:132.
116.
HedbladMA, BorglundE.Precursor lesion of malignant melanoma in xeroderma pigmentosum: reflections about solar lentigo as the precursor. J Am Acad Dermatol1995;32:680–682.
117.
FisherSR, ReintgenDS, SeiglerHF. Juvenile malignant melanoma of the head and neck. Laryngoscope1988;98:184–191.
118.
SmithKJ, BarrettTL, SkeltonHG, LuptonGP, GrahamJH. Spindle cell and epitheloid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol1989;13:931–939.
119.
VeronesiU, CascinelliN.Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg1991;126:438–441.
120.
HoVC, SoberAJ. Therapy for cutaneous melanoma: an update. J Am Acad Dermatol1990;22:159–176.
121.
AtkinsMB. The treatment of metastatic melanoma with chemotherapy and biologics. Curr Opin Oncol1997;9:205–213.
122.
SmithNP. The pigmented spindle cell tumor of Reed: an underdiagnosed lesion. Semin Diagn Pathol1987;4:75–87.
